Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Researchers develop new technique to more efficiently isolate and identify rare T cells

Scientists from the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed a technique that will enable researchers to more efficiently isolate and identify rare T cells that are capable of targeting viruses, cancer and other diseases.

12 Jan 2021

Common gene expression changes at target tissues of four autoimmune diseases found

Autoimmune diseases are diseases of "mistaken identity", where the immune system - which is supposed to protect us against infectious diseases and neoplasias - mistakenly attacks and destroys components of our own body.

7 Jan 2021

New approach can help identify novel treatments for autoimmune diseases

A team of researchers led by the Indiana Biosciences Research Institute Diabetes Center's Scientific Director Decio L. Eizirik, MD, PhD, has found that identifying new treatments for autoimmune diseases requires studying together the immune system AND target tissues.

7 Jan 2021

Dr. Genova wins K18 award to advance research on transition-age youth with autism

Helen M. Genova, PhD, of Kessler Foundation, was awarded a two-year K18 grant for $266,988 from the NIH's National Institute of Mental Health - the NIMH Career Enhancement Award to Advance Autism Services Research for Adults and Transition-Age Youth.

28 Dec 2020

New therapeutic strategy designed to improve kidney function after lung transplantation

The Covid-19 pandemic shows the importance of medical research in the treatment of lung diseases. The Medical University of Vienna is renowned the world over in the field of lung transplantation medicine.

23 Dec 2020

Researchers explore why seizures happen in a subset of MS patients

A research team at the University of California, Riverside School of Medicine has identified a pathway involving astrocytes, a class of central nervous system support cells, that could shed light on why seizures happen in a subset of multiple sclerosis, or MS, patients.

21 Dec 2020

Researchers demonstrate potential preventive treatment for Crohn's disease

A potential preventive treatment for Crohn's disease, a form of inflammatory bowel disease, has been demonstrated in a mouse model and using immune-reactive T cells from patients with Crohn's disease.

21 Dec 2020

Microglial surveillance helps prevent seizure activity in the brain

An important part of the brain's immune system, cells called microglia constantly extend and retract "branches" from their cell body to survey their environment.

14 Dec 2020

Compound derived from thunder god vine could improve outcomes for pancreatic cancer patients

The results of a pre-clinical study led by researchers at the Translational Genomics Research Institute, an affiliate of City of Hope, suggest how a compound derived from the thunder god vine -- an herb used in China for centuries to treat joint pain, swelling and fever -- is able to kill cancer cells and potentially improve clinical outcomes for patients with pancreatic cancer.

14 Dec 2020

Researchers receive $651,997 funding to study memory dysfunction in MS

Researchers at Montclair State University and Kessler Foundation have received funding totaling $651,997 from the National Multiple Sclerosis Society to measure memory-related abilities in individuals with and without multiple sclerosis (MS) for clues to how such cognitive processes are altered by MS. Joshua Sandry, PhD, assistant professor of psychology at Montclair State and Ekaterina Dobryakova, PhD, research scientist in the Center for Traumatic Brain Injury Research at Kessler Foundation, collaborate on the 4-year study, titled "Neuroimaging of Hippocampally Mediated Memory Dysfunction in Multiple Sclerosis."

10 Dec 2020

Study describes novel aging clock trained to predict human age

Deep Longevity, a Hong-Kong based longevity startup, has published their research on the epigenetics of aging in the Aging and Disease journal.

9 Dec 2020

Experimental drug can reverse age-related memory decline in mice

Just a few doses of an experimental drug can reverse age-related declines in memory and mental flexibility in mice, according to a new study by UC San Francisco scientists.

1 Dec 2020

New technique may help assess hand injuries

Scratch your nose. Write a text message. Reach for a glass of water. Most people take these simple movements -- brain-hand behaviors -- for granted.

1 Dec 2020

Researchers receive three-year grant to develop treatment for traumatic brain injury

Researchers at Montclair State University and Kessler Foundation received a three-year $456,710 grant from the New Jersey Commission on Brain Injury Research to develop treatment interventions for the deficits in long-term memory that hinder recovery after traumatic brain injury (TBI).

30 Nov 2020

COVID-19 may trigger recurrent Guillain–Barré Syndrome episodes, a case study shows

A team of researchers at the Robert Wood Johnson Medical School, Rutgers University, USA, have investigated a case wherein a man experienced recurrent episodes of Guillain–Barré Syndrome after being infected with SARS-CoV-2.

26 Nov 2020

Genetic modification in ‘coat’ of fatal brain virus may allow it to escape antibodies

A genetic modification in the 'coat' of a brain infection-causing virus may allow it to escape antibodies, according to Penn State College of Medicine researchers.

20 Nov 2020

Scientists receive funds at 2020 event hosted by Center for BrainHealth

The Center for BrainHealth, part of The University of Texas at Dallas, recently hosted the first-ever virtual iteration of the annual Friends of BrainHealth Scientist Selection Luncheon, during which the following scientists were awarded funds for their independently designed research studies.

18 Nov 2020

Promising MS drug may make the debilitating disease worse

A drug that has shown promise for treating multiple sclerosis may actually make the debilitating disease worse, new research from the University of Virginia School of Medicine suggests.

15 Nov 2020

Inhaled nebulized interferon beta-1a (SNG001) helps COVID-19 patients recovers

Now, a team of researchers at the Synairgen Research, Southampton General Hospital, Southampton, United Kingdom, has found that inhaled nebulized interferon beta-1a (SNG001), a drug used for multiple sclerosis, helped COVID-19 patients have greater odds of improvement and recovery from SARS-CoV-2 infection.

15 Nov 2020

Study focuses on efficacy of cognitive rehabilitation across a range of neurological conditions

A new text by Kessler Foundation scientists focuses on the efficacy of cognitive rehabilitation across a variety of neurological conditions, with specific emphasis on treatment-related changes in the brain detectable via neuroimaging.

11 Nov 2020

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Researchers develop new technique to more efficiently isolate and identify rare T cells

Common gene expression changes at target tissues of four autoimmune diseases found

New approach can help identify novel treatments for autoimmune diseases

Dr. Genova wins K18 award to advance research on transition-age youth with autism

New therapeutic strategy designed to improve kidney function after lung transplantation

Researchers explore why seizures happen in a subset of MS patients

Researchers demonstrate potential preventive treatment for Crohn's disease

Microglial surveillance helps prevent seizure activity in the brain

Compound derived from thunder god vine could improve outcomes for pancreatic cancer patients

Researchers receive $651,997 funding to study memory dysfunction in MS

Study describes novel aging clock trained to predict human age

Experimental drug can reverse age-related memory decline in mice

New technique may help assess hand injuries

Researchers receive three-year grant to develop treatment for traumatic brain injury

COVID-19 may trigger recurrent Guillain–Barré Syndrome episodes, a case study shows

Genetic modification in ‘coat’ of fatal brain virus may allow it to escape antibodies

Scientists receive funds at 2020 event hosted by Center for BrainHealth

Promising MS drug may make the debilitating disease worse

Inhaled nebulized interferon beta-1a (SNG001) helps COVID-19 patients recovers

Study focuses on efficacy of cognitive rehabilitation across a range of neurological conditions

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in